BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8543410)

  • 1. Immunohistochemistry in histoid leprosy.
    Kontochristopoulos GJ; Aroni K; Panteleos DN; Tosca AD
    Int J Dermatol; 1995 Nov; 34(11):777-81. PubMed ID: 8543410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of CD34-positive dendritic cells of human dermis.
    Narvaez D; Kanitakis J; Faure M; Claudy A
    Am J Dermatopathol; 1996 Jun; 18(3):283-8. PubMed ID: 8806963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multibacillary leprosy: lesions with macrophages positive for S100 protein and dendritic cells positive for Factor 13a.
    Cuevas-Santos J; Contreras F; McNutt NS
    J Cutan Pathol; 1998 Nov; 25(10):530-7. PubMed ID: 9870671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wade histoid leprosy: histological and immunohistochemical analysis.
    Da Costa DA; Enokihara MM; Nonogaki S; Maeda SM; Porro AM; Tomimori J
    Lepr Rev; 2013 Sep; 84(3):176-85. PubMed ID: 24428111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of defective cytokine activity within lepromatous leprosy lesions.
    Volc-Platzer B; Kremsner P; Stemberger H; Wiedermann G
    Zentralbl Bakteriol; 1990 Apr; 272(4):458-66. PubMed ID: 1972881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does histoid leprosy represent a locally hyperimmune variant of lepromatous leprosy?
    Malhotra KP; Suvirya S; Malhotra HS; Kumar B; Gupta A
    QJM; 2019 Jun; 112(6):429-435. PubMed ID: 30778548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity.
    Sieling PA; Jullien D; Dahlem M; Tedder TF; Rea TH; Modlin RL; Porcelli SA
    J Immunol; 1999 Feb; 162(3):1851-8. PubMed ID: 9973451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1-positive epidermal Langerhans cells in regressed tuberculoid and lepromatous leprosy lesions.
    Narayanan RB; Girdhar A; Girdhar BK
    Int Arch Allergy Appl Immunol; 1990; 92(1):94-6. PubMed ID: 1700968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata: immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors.
    Ghersetich I; Campanile G; Lotti T
    Int J Dermatol; 1996 Jan; 35(1):28-33. PubMed ID: 8838925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted.
    Meunier L; Bata-Csorgo Z; Cooper KD
    J Invest Dermatol; 1995 Dec; 105(6):782-8. PubMed ID: 7490472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells (CD1a and CD207), dermal dendrocytes (FXIIIa) and plasmacytoid dendritic cells (CD123) in skin lesions of leprosy patients.
    Hirai KE; Aarão TL; Silva LM; de Sousa JR; de Souza J; Dias LB; Carneiro FR; Fuzii HT; Quaresma JA
    Microb Pathog; 2016 Feb; 91():18-25. PubMed ID: 26639680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.
    Collings LA; Tidman N; Poulter LW
    Clin Exp Immunol; 1985 Jul; 61(1):58-66. PubMed ID: 3862470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesional T-cell subset in leprosy and leprosy reaction.
    Mahaisavariya P; Kulthanan K; Khemngern S; Pinkaew S
    Int J Dermatol; 1999 May; 38(5):345-7. PubMed ID: 10369542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1a and factor XIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection.
    Simões Quaresma JA; de Oliveira MF; Ribeiro Guimarães AC; de Brito EB; de Brito RB; Pagliari C; de Brito AC; Xavier MB; Seixas Duarte MI
    Am J Dermatopathol; 2009 Aug; 31(6):527-31. PubMed ID: 19590423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.
    Narayanan RB; Bhutani LK; Sharma AK; Nath I
    Clin Exp Immunol; 1983 Mar; 51(3):421-9. PubMed ID: 6342880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective intralesional interferon-gamma activity in patients with lepromatous leprosy.
    Volc-Platzer B; Stemberger H; Luger T; Radaszkiewicz T; Wiedermann G
    Clin Exp Immunol; 1988 Feb; 71(2):235-40. PubMed ID: 2450707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological analysis of nerve granulomas in neuritic leprosy.
    Narayanan RB; Girdhar A; Girdhar BK; Malaviya GN
    Int Arch Allergy Appl Immunol; 1990; 92(1):50-5. PubMed ID: 2246076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.
    Rea TH; Shen JY; Modlin RL
    Clin Exp Immunol; 1986 Aug; 65(2):253-9. PubMed ID: 2431817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment on the histopathology of leprosy.
    Cree IA; Coghill G; Subedi AM; Abbot NC; Butlin SR; Samson PD; Beck JS
    J Clin Pathol; 1995 Apr; 48(4):304-7. PubMed ID: 7615846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.